European Union - English - EMA (European Medicines Agency)

eli lilly nederland b.v. - drotrecogin alfa (activated) - sepsis; multiple organ failure - antithrombotic agents - xigris is indicated for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. the use of xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure (for further information see section 5.1).

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 46426 - orthopaedic cartilage repair membrane - chondro gide is a bilayer collagen matrix used to cover articular cartilage defects treated with autologus chondrocyte transplantation or bone marrow stimulation techniques chondro-gide? is used to cover chondral or osteochondral defects treated with bone marrow stimulation techniques (e.g. amic? ? autologous matrix induced chondrogenesis). surgical approaches include arthrotomy or arthroscopy. the defects can be acute or chronic and be caused by a fall, accident or other traumatic events. defects are located at articular cartilage surfaces including hyaline cartilage in the knee, hip, and talus.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58709 - collagen dental regeneration membrane - the devices porous surface facing the bone allows for the ingrowth of bone-forming cells. the dense surface facing the soft tissue prevents the ingrowth of fibrous tissue into the defect. the fibrous microstructure is hydrophilic and readily absorbs fluid and retains its structural integrity when wet. in vivo degradation of the membrane takes several months depending on the surgical site, vascularization and patient comorbidities. the membrane is not radio-opaque. geistlich bio-gide shape is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits. geistlich bio-gide shape is designed to be used for the treatment of alveolar bone defects in extraction sockets. geistlich bio-gide shape can also be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 47968 - dental bone matrix implant, animal-derived - a combined kit containing geistlich bio-oss collagen 100mg and geistlich bio-gide perio 16 x 22 mm. bio- oss: the spongy consistency of the material allows simple trimming. the collagen facilitates adaptation to the defect site. the collagen is slowly resorbed over several weeks. bio-gide perio: the duration of barrier function ensures sufficient bone formation time for the indications. the fibrous microstructure is hydrophilic and retains its structural integrity when wet. geistlich bio-oss collagen is intended to be used in the treatment of hard tissue defects in oral-maxillofacial surgery; and is indicated in the following clinical situations: bone deficiencies in the alveolar ridge; dentofacial anomalies and malformations. geistlich bio-gide perio is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits; and is indicated to be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 47968 - dental bone matrix implant, animal-derived - a combined kit containing geistlich bio-oss collagen 100mg and geistlich bio-gide 16 x 22 mm. bio-oss: the spongy consistency of the material allows simple trimming. the collagen facilitates adaptation to the defect site. the collagen is slowly resorbed over several weeks. bio-gide: the duration of barrier function ensures sufficient bone formation time for the indications. the fibrous microstructure is hydrophilic and retains its structural integrity when wet. to be used in the regeneration of bone defects. geistlich bio-oss collagen is intended to be used in the treatment of hard tissue defects in oral-maxillofacial surgery; and is indicated in the following clinical situations: bone deficiencies in the alveolar ridge; dentofacial anomalies and malformations; and geistlich bio-gide is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits; and is indicated to be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58709 - collagen dental regeneration membrane - the devices porous surface facing the bone allows for the ingrowth of bone-forming cells. the dense surface facing the soft tissue prevents the ingrowth of fibrous tissue into the defect. the fibrous microstructure is hydrophilic and readily absorbs fluid and retains its structural integrity when wet. in vivo degradation of the membrane takes several months depending on the surgical site, vascularization and patient comorbidities. the membrane is not radio-opaque. geistlich bio-gide perio is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits. geistlich bio-gide perio is indicated to be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58709 - collagen dental regeneration membrane - the devices porous surface facing the bone allows for the ingrowth of bone-forming cells. the dense surface facing the soft tissue prevents the ingrowth of fibrous tissue into the defect. the fibrous microstructure is hydrophilic and readily absorbs fluid and retains its structural integrity when wet. in vivo degradation of the membrane takes several months depending on the surgical site, vascularization and patient comorbidities. the membrane is not radio-opaque. geistlich bio-gide is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits. geistlich bio-gide is indicated to be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58740 - dental soft-tissue matrix implant, animal-derived - has a bilayer structure - a dense layer consists of compact collagen which has cell occlusive properties and allows tissue adherence for wound healing. this layer has a smooth texture with elastic properties to allow fixation by sutures or pins. a 2nd layer consists of a spongeous collagen which readily absorbs fluid. this surface is placed next to the host tissue to facilitate organization of the blood clot and to promote formation of new blood vessels and tissue integration. geistlich mucograft? seal is intended to be used in closed and open healing situations to support wound healing and regeneration processes in case of oral mucosa defects and deficiencies. the concerned oral mucosa defects and deficiencies may be surgically created or result from traumatic injuries, pathological conditions (congenital or acquired), medical treatments and therapies, or history of personal lifestyle habits. geistlich mucograft? is indicated to be used in the surgical treatment of the following clinical conditions: defects and deficiencies of oral mucosa associated with: presence of recessions lack of keratinized tissue oral mucosa wounds associated with: bone regeneration procedures lack of soft tissue.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 47968 - dental bone matrix implant, animal-derived - geistlich bio-oss collagen is a mixture of 90% geistlich bio-oss (granules 0.25 ? 1 mm) and 10% porcine collagen fibres in a block form. the collagen facilitates adaptation to the defect site and is slowly resorbed within several weeks. the inorganic bone matrix has a macro? and microporous structure similar to human spongious bone & the formation and ingrowth of new bone at the implantation site is encouraged. in the course of time this is partially remodelled by osteoclasts and osteoblasts. geistlich bio-oss collagen is intended to be used in the treatment of hard tissue defects in oral-maxillofacial surgery. geistlich bio-oss collagen is indicated in the following clinical situations: bone deficiencies in the alveolar ridge; dentofacial anomalies and malformations.

Australia - English - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58740 - dental soft-tissue matrix implant, animal-derived - has a bilayer structure - a dense layer consists of compact collagen which has cell occlusive properties and allows tissue adherence for wound healing. this layer has a smooth texture with elastic properties to allow fixation by sutures or pins. a 2nd layer consists of a spongeous collagen which readily absorbs fluid. this surface is placed next to the host tissue to facilitate organization of the blood clot and to promote formation of new blood vessels and tissue integration. geistlich mucograft? is intended to be used in closed and open healing situations to support wound healing and regeneration processes in case of oral mucosa defects and deficiencies. the concerned oral mucosa defects and deficiencies may be surgically created or result from traumatic injuries, pathological conditions (congenital or acquired), medical treatments and therapies, or history of personal lifestyle habits. geistlich mucograft? is indicated to be used in the surgical treatment of the following clinical conditions: defects and deficiencies of oral mucosa associated with: - presence of recessions - lack of keratinized tissue oral mucosa wounds associated with: - bone regeneration procedures - lack of soft tissue.